secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2024-07-22T23:59:59+00:00
Accession:  0001437749-24-023137
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 1.02, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics raises $12.9M via Series C Preferred and Warrants; cancels $9.5M debt
--------------------------------------------------------------------------------

- Gross proceeds of ~$12.9M from private placement of Series C Convertible Preferred Stock and warrants; $9.5M used to cancel existing convertible notes, secured notes, and Series B preferred shares.
- Series C Preferred has stated value $1,000/share, initial conversion price $3.74, convertible into 267 shares of common; 10% dividend rate (18% default).
- Warrants to purchase up to 3,440,631 shares of common at $4.11/share, exercisable starting 6 months + 1 day after issuance, expiring 5 years later.
- Company issues 161 Preferred Shares and 42,838 Warrants as placement agent compensation.
- Company agrees to seek stockholder approval for share issuance; restricted period of 90 trading days with no further equity-linked issuances without consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774924023137/0001437749-24-023137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774924023137/wint20240718_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-023137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer